Abstract
Vitamin D receptors (VDRs) are associated with the occurrence and development of asthma. The aim of the present study was to analyze the secondary structure and B-cell and T-cell epitopes of VDR using online prediction software and aid in the future development of a highly efficient epitope-based vaccine against asthma. Blood samples were collected from peripheral blood of asthmatic children. Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) was performed to detect the expression of VDR in the peripheral blood. Mouse models of asthma were established. Hematoxylin and eosin staining was performed to observe the pathological alterations of the lungs of mice. Immunohistochemistry, western blot analysis and RT-qPCR were performed to detect the expression of VDR in the lungs of asthmatic mice. Online prediction software immune epitope database and analysis resource, SYFPEITHI and linear epitope prediction based on propensity scale and support vector machines were used to predict the B-cell and T-cell epitopes and the RasMol and 3DLigandSite were used to analyze the tertiary structure of VDR. RT-qPCR demonstrated that VDR expression in the peripheral blood of asthmatic children was decreased. Immunohistochemistry, western blotting and RT-qPCR demonstrated that VDR expression also decreased in the lungs of mouse models of asthma. VDR B-cell epitopes were identified at 37–45, 88–94, 123–131, 231–239, 286–294 and 342–350 positions of the amino acid sequence and VDR T-cell epitopes were identified at 125–130, 231–239 and 265–272 positions. A total of six B-cell epitopes and three T-cell epitopes for VDR were predicted by bioinformatics, which when validated, may in the future aid in immunological diagnosis and development of a targeted drug therapy for clinical asthma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.